Literature DB >> 17222906

The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells.

Kelly J Morgan1, Matthew A Rowley, Stephen M Wiesner, Diane E Hasz, Brian Van Ness, David A Largaespada.   

Abstract

Inactivation of the NF1 tumor suppressor causes myeloproliferative diseases. NF1 encodes a GTPase activating protein (GAP) for Ras. Myeloid cells with loss of NF1 have high levels of Ras-GTP, functionally equivalent to the effects of RAS oncogenes. We investigated the effects of the NF1 GAP-related domain (GRD) in proliferation, apoptosis and Ras-GTP levels in Nf1-negative acute myeloid leukemia (AML) cells. In AML cells, with cooperating mutations, the expression of the neurofibromin GRD causes significant reductions of N- and K-Ras-GTP levels, which is not incompatible with AML cell survival, but which is strongly selected against due to suppression of proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222906      PMCID: PMC2788398          DOI: 10.1016/j.leukres.2006.11.022

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  32 in total

1.  Essential role for oncogenic Ras in tumour maintenance.

Authors:  L Chin; A Tam; J Pomerantz; M Wong; J Holash; N Bardeesy; Q Shen; R O'Hagan; J Pantginis; H Zhou; J W Horner; C Cordon-Cardo; G D Yancopoulos; R A DePinho
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

2.  RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML).

Authors:  C Flotho; S Valcamonica; S Mach-Pascual; G Schmahl; L Corral; J Ritterbach; H Hasle; M Aricò; A Biondi; C M Niemeyer
Journal:  Leukemia       Date:  1999-01       Impact factor: 11.528

3.  Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.

Authors:  Y Li; R White
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

Review 4.  Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy.

Authors:  P D Emanuel; K M Shannon; R P Castleberry
Journal:  Mol Med Today       Date:  1996-11

5.  Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.

Authors:  J H Kersey; D Wang; M Oberto
Journal:  Leukemia       Date:  1998-10       Impact factor: 11.528

6.  Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.

Authors:  D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia.

Authors:  D A Largaespada; C I Brannan; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

8.  Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

Authors:  L E Side; P D Emanuel; B Taylor; J Franklin; P Thompson; R P Castleberry; K M Shannon
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

9.  Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).

Authors:  J Griesser; D Kaufmann; I Eisenbarth; C Bäuerle; W Krone
Journal:  Biol Chem Hoppe Seyler       Date:  1995-02

10.  Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.

Authors:  C A Stiller; J M Chessells; M Fitchett
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  4 in total

1.  Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.

Authors:  Nicole M Brossier; Amanda M Prechtl; Jody Fromm Longo; Stephen Barnes; Landon S Wilson; Stephanie J Byer; Stephanie N Brosius; Steven L Carroll
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

2.  Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: a molecular modeling and dynamics approach.

Authors:  Ashish Kumar Agrahari; Meghana Muskan; C George Priya Doss; R Siva; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-05-27       Impact factor: 3.584

Review 3.  Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.

Authors:  David H Gutmann
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

4.  Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies.

Authors:  Tahir N Sheikh; Parag P Patwardhan; Serge Cremers; Gary K Schwartz
Journal:  Oncotarget       Date:  2017-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.